Muscle weakness and associated diseases are likely to place a considerable economic burden on government health care expenditure. Therefore, our aim for this study was to estimate the direct and indirect costs associated with muscle weakness in the Czech Republic. We applied a cost-of-illness approach using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). Six hundred and eighty-nine participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with gamma distribution was used, and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR =2.11), but did not have a statistically significant impact on indirect costs (OR =1.08) or on total cost (OR =1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR =2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs, and consequently place a burden on health care expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness among older people in the Czech Republic.

Centre of Expertise in Longevity and Long term Care Faculty of Humanities Charles University Prague Czech Republic

Department of Physiology and Biochemistry Faculty of Physical Education and Sport Charles University Prague Czech Republic

Department of Sport Management Faculty of Physical Education and Sport Charles University Prague Czech Republic

Zobrazit více v PubMed

Marx J, Hockberger R, Walls R. Rosen’s Emergency Medicine – Concepts and Clinical Practice. Philadelphia: Mosby/Elsevier; 2014.

Bandeen-Roche K, Xue QL, Ferrucci L, et al. Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61(3):262–266. PubMed

Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–256. PubMed PMC

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European Working Group on Sarcopenia in Older People Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. PubMed PMC

Comans TA, Peel NM, Hubbard RE, Mulligan AD, Gray LC, Scuffham PA. The increase in healthcare costs associated with frailty in older people discharged to a post-acute transition care program. Age Ageing. 2016;45(2):317–320. PubMed

Bock JO, Konig HH, Brenner H, et al. Associations of frailty with health care costs results of the ESTHER cohort study. BMC Health Serv Res. 2016;16:128. PubMed PMC

Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–85. PubMed

García-Nogueras I, Aranda-Reneo I, Peña-Longobardo LM, Oliva-Moreno J, Abizanda P. Use of health resources and healthcare costs associated with frailty: the FRADEA study. J Nutr Health Aging. 2017;21(2):207–214. PubMed

Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle. 2014;5(4):253–259. PubMed PMC

Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013;42(2):203–209. PubMed

Borst SE. Interventions for sarcopenia and muscle weakness in older people. Age Ageing. 2004;33(6):548–555. PubMed

Fried TR, Bradley EH, Williams CS, Tinetti ME. Functional disability and health care expenditures for older persons. Arch Intern Med. 2001;161(21):2602–2607. PubMed

Börsch-Supan A. Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 6. 2017. Release version: 6.0.0. SHARE-ERIC. Data set. PubMed DOI PMC

Börsch-Supan A, Brandt M, Hunkler C, et al. SHARE Central Coordination Team Data resource profile: the Survey of Health, Ageing and Retirement in Europe (SHARE) Int J Epidemiol. 2013;42(4):992–1001. PubMed PMC

McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014;69(5):576–583. PubMed PMC

Andersen-Ranberg K, Petersen I, Frederiksen H, Mackenbach JP, Christensen K. Cross-national differences in grip strength among 50+ year-old Europeans: results from the SHARE study. Eur J Ageing. 2009;6(3):227–236. PubMed PMC

Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–337. PubMed PMC

Clabaugh G, Ward MM. Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost. Value Health. 2008;11(1):13–21. PubMed

Robinson TN, Wu DS, Stiegmann GV, Moss M. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg. 2011;202(5):511–514. PubMed PMC

Butler A, Gallagher D, Gillespie P, et al. Frailty: a costly phenomenon in caring for elders with cognitive impairment. Int J Geriatr Psychiatry. 2016;31(2):161–168. PubMed

Peters LL, Burgerhof JG, Boter H, Wild B, Buskens E, Slaets JP. Predictive validity of a frailty measure (GFI) and a case complexity measure (IM-E-SA) on healthcare costs in an elderly population. J Psychosom Res. 2015;79(5):404–411. PubMed

Rousculp MD, Long SR, Wang S, Schoenfeld MJ, Meadows ES. Economic burden of osteoporosis-related fractures in Medicaid. Value Health. 2007;10(2):144–152. PubMed

Svedbom A, Ivergard M, Hernlund E, Rizzoli R, Kanis JA. Epidemiology and economic burden of osteoporosis in Switzerland. Arch Osteoporos. 2014;9:187. PubMed

Bleibler F, Konnopka A, Benzinger P, Rapp K, Konig HH. The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany a demographic simulation model. Osteoporos Int. 2013;24(3):835–847. PubMed

OECD . Health at a Glance 2015: OECD Indicators. Paris: OECD Publishing; 2015. Expenditure by disease and age.

Guerra RS, Amaral TF, Sousa AS, et al. Handgrip strength measurement as a predictor of hospitalization costs. Eur J Clin Nutr. 2015;69(2):187–192. PubMed

Steffl M, Bohannon RW, Sontakova L, Tufano JJ, Shiells K, Holmerova I. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017;12:835–845. PubMed PMC

Sarcopenia: revised European consensus on definition and diagnosis